| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $34.33M | - | |
| CEO | 411.2K | $32.69M | - | |
| CFO | 230.9K | $18.35M | - | |
| VP | 158.5K | $12.60M | - | |
| Other | 91.3K | $7.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 | Gutwerg Ori47 | SVP, Generics | Sale+OE | 15,561 | $62.39 | $970,850.79 | -11.2% | -18.8% | -5.1% | |
| Aug 23, 2023 | Marken James G.47 | SVP Ops &Prod Dev | Sale+OE | 3,932 | $63.00 | $247,716.00 | -2.9% | -18.8% | -5.1% | |
| Aug 16, 2023 | Meridian Venture Partners II LP | 10% Owner | Sell | 200,000 | $58.50 | $11,700,000.00 | -9.9% | -10.4% | +2.9% | |
| Aug 15, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $61.35 | $3,067,449.50 | -2.1% | -16.5% | -4.3% | |
| Aug 15, 2023 | Lalwani Nikhil66 | President &CEO | Sale+OE | 68,282 | $58.32 | $3,982,547.58 | -8.8% | -16.5% | -4.3% | |
| Aug 14, 2023 | Pera Antonio R58 | Director | Sell | 3,000 | $60.37 | $181,110.00 | -8.2% | -15.5% | -3.5% | |
| Aug 14, 2023 | Carey Stephen P.55 | SVP &CFO | Sell | 17,639 | $61.37 | $1,082,505.43 | -10.2% | -15.5% | -3.5% | |
| Aug 1, 2023 | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $51.06 | $1,021,200.00 | -5.7% | +19.1% | +29.4% | |
| Jul 21, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 23,469 | $52.02 | $1,220,844.12 | -0.6% | +9.8% | +19.2% | |
| Jul 18, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 26,531 | $51.02 | $1,353,598.86 | -0.7% | +12.9% | +21.4% |